Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salkera Emollient Foam for Moderate to Severe Keratosis Pilaris
NCT00944216Phase 4Terminated
- Sponsor
- Wright State University
- Start
- Jun 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Salvax in keratosis pilaris (KP), sponsored by Wright State University. Started Jun 2009; status: terminated.
02
Drugs
Salvax
03
Conditions
keratosis pilaris (KP)
Beyond the preview
Go deeper on NCT00944216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944216.